Abstract:OBJECTIVE:Single chain antibody-mediated delivery is a novel approach for targeting shRNA to appropriate cells. In this report, we studied whether this shRNA delivery strategy would be effective against rabies virus.METHODS:Rabies virus scFv (G) gene and ETA-GAL4 gene were amplified by PCR from vector scFv (G)-T and PE40-GAL4-T respectively. Then, the chimeric gene scFv (G)-ETA-GAL4 was constructed by lapextension PCR and cloned into the prokaryotic expression vector pET28a( +). Recombinant expression plasmid of pET28a(+)-scFv(G)-ETA-GAL4 was constructed and then transformed into the competent E. coli BL21 (DE3) cells for expression under the induction of IPTG. scFv(G)-ETA-GAL4 protein was purified by Ni-NTA His Bind Resin affinity chromatograph and identified by SDS-PAGE gel and Western blot assay. Binding of the fusion protein scFv(G)-ETA-GAL4 to rabies virus was determined by ELISA. Complexes which formed spontaneously by the fusion protein scFv(G)-ETA-GAL4 with plasmid pRNATU6.3-shRNA were added to BHK-21 cells culture medium that infected with RV. Green fluorescent protein (GFP) was observed after 35 h and judged the transferring efficiency of the complexes. The inhibition of RV replication by shRNA was detected by direct immune fluorescence test.RESULTS:A 1557 bp DNA encoding scFv (G)-ETA-GAL4 protein gene was cloned and successfully expressed in inclusion body with approximate molecular weight of 57.0 kDa, which could be recognized by anti-His mAb. The scFv(G)-ETA-GAL4 proteins were purified by Ni-NTA column , and after renatured with the yield of 2.8 mg/mL. The ELISA results showed that when concentration of the scFv(G)-ETA-GAL4 protein ranging from 2.8 nmol/L to 1000 nmol/L, binding affinity is directly related with RV. The GFP expressed in BHK-21 cell after transfection with the complexes and effectively inhibited RV replication in BHK-21 cell.CONCLUSION:scFv(G)-ETA-GAL4 fusion protein could mediated plasmid pRNATU6.3-shRNA transferred into BHK-21 cell infected with RV, and then inhibited RV replication.

Small Interfering Rnas Targeting the Rabies Virus Nucleoprotein Gene

Adeno-associated viruses serotype 2-mediated RNA interference efficiently inhibits rabies virus replication in vitro and in vivo.

Rabies Prophylactic and Treatment Options: An In Vitro Study of siRNA- and Aptamer-Based Therapeutics

[Targeted Inhibition of Rabies Virus Gene Expression by a Chimeric Multidomain Protein Mediated Shrna Delivery].

[Targeted Inhibition of Rabies Virus Replication in Vitro by Single Chain Antibody Domain Mediated Vector Expression Shrna Delivery].

Inhibition of Gene Expression Directed by Small Interfering Rnas in Infectious Bronchitis Virus

Isolation of ssDNA aptamers that inhibit rabies virus

Selection of an aptamer against rabies virus: a new class of molecules with antiviral activity.

Effective Small Interfering RNAs Targeting Matrix and Nucleocapsid Protein Gene Inhibit Influenza A Virus Replication in Cells and Mice

Small Interfering RNAs Are Highly Effective Inhibitors of Crimean-Congo Hemorrhagic Fever Virus Replication In Vitro

Inhibition of Severe Acute Respiratory Syndrome Virus Replication by Small Interfering RNAs in Mammalian Cells

In silico structural elucidation of the rabies RNA-dependent RNA polymerase (RdRp) toward the identification of potential rabies virus inhibitors

RNA Interference Targeting Nucleocapsid Protein Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication in Marc-145 Cells.

Small Interfering Rna-Mediated Inhibition Of Respiratory Syncytial Virus Infections In Hela Cells

A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice

Small interfering RNAs are highly effective inhibitors regarding Crimean-Congo hemorrhagic fever virus replication in vitro

Inhibition of Rabies Virus Infection by an Oligodeoxynucleotide Complementary to Rabies Virus Genomic RNA.

Establishment of an expression vector of NgR-specific siRNA

Clofazimine: A Promising Inhibitor of Rabies Virus

RNA Interference Targeting VP1 Inhibits Foot-and-Mouth Disease Virus Replication in BHK-21 Cells and Suckling Mice

Prophylactic and Therapeutic Effects of Small Interfering RNA Targeting SARS-coronavirus.